Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek M Fine

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The American Journal of Medicine|November 8, 2005
Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathyMohamed G Atta, Michael J Choi, J Craig Longenecker, et al.
BMC Nephrology|September 5, 2020
Interventions Made to Preserve Cognitive Function Trial (IMPCT) study protocol: a multi-dialysis center 2x2 factorial randomized controlled trial of intradialytic cognitive and exercise training to preserve cognitive functionMara A McAdams-DeMarco, Nadia M Chu, Malu Steckel, et al.
Kidney International|April 13, 2012
HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristicsMohamed G Atta, Michelle M Estrella, Michael Kuperman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 16, 2015
Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney BiopsyMohamed G Atta, Michelle M Estrella, Karl L Skorecki, et al.
Kidney International|November 10, 2022
Viral associations with kidney disease diagnosis and altered kidney metatranscriptome by kidney functionChangjin Hong, Felix Eichinger, Mohamed G Atta, et al.
American Journal of Nephrology|May 11, 2025
Intradialytic Cognitive and Aerobic Exercise Training to Preserve Cognitive Function: IMPCT, A Multi-Dialysis Center 2x2 Factorial Block-Randomized Controlled TrialNidhi Ghildayal, Yi Liu, Jingyao Hong, et al.
The Journal of Infectious Diseases|August 2, 2013
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individualsGregory M Lucas, Yuezhou Jing, Mark Sulkowski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2020
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case reportMuhammad Baraa Hammami, Brian Garibaldi, Pali Shah, et al.
The Journal of Infectious Diseases|May 28, 2014
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infectionNetanya G Sandler, Xinyan Zhang, Ronald J Bosch, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment responseRufei Lu, Catriona A Wagner, Andrea Fava, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The American Journal of Medicine|November 8, 2005
Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathyMohamed G Atta, Michael J Choi, J Craig Longenecker, et al.
BMC Nephrology|September 5, 2020
Interventions Made to Preserve Cognitive Function Trial (IMPCT) study protocol: a multi-dialysis center 2x2 factorial randomized controlled trial of intradialytic cognitive and exercise training to preserve cognitive functionMara A McAdams-DeMarco, Nadia M Chu, Malu Steckel, et al.
Kidney International|April 13, 2012
HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristicsMohamed G Atta, Michelle M Estrella, Michael Kuperman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 16, 2015
Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney BiopsyMohamed G Atta, Michelle M Estrella, Karl L Skorecki, et al.
Kidney International|November 10, 2022
Viral associations with kidney disease diagnosis and altered kidney metatranscriptome by kidney functionChangjin Hong, Felix Eichinger, Mohamed G Atta, et al.
American Journal of Nephrology|May 11, 2025
Intradialytic Cognitive and Aerobic Exercise Training to Preserve Cognitive Function: IMPCT, A Multi-Dialysis Center 2x2 Factorial Block-Randomized Controlled TrialNidhi Ghildayal, Yi Liu, Jingyao Hong, et al.
The Journal of Infectious Diseases|August 2, 2013
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individualsGregory M Lucas, Yuezhou Jing, Mark Sulkowski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2020
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case reportMuhammad Baraa Hammami, Brian Garibaldi, Pali Shah, et al.
The Journal of Infectious Diseases|May 28, 2014
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infectionNetanya G Sandler, Xinyan Zhang, Ronald J Bosch, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment responseRufei Lu, Catriona A Wagner, Andrea Fava, et al.
Pageof 10